Zynex, Inc. ZYXI
Set alert
At close · Apr 2
After hours · Apr 2, 4:00 PM ET
- YTD
- -98.44%
- 1 year
- -98.48%
- Open
- 0.125
- Prev close
- 0.125
- Mkt cap
- 261.77M
- Vol
- 274.57K
- Avg vol
- 90.03K
- EPS
- 0.14
- P/E
- 58.71
- Div yield
- 0.00%
More statistics
- Low
- 0.125
- High
- 0.125
- Forward P/E
- 17.13
- Beta
- 0.54
- Short ratio
- 54.23
- Inst. own
- 28.01%
- Dividend
- 0.00
- Ex-div date
- Jan 4, 2022
- Earnings
- Nov 30, 2019
- 50-d avg
- 8.33
- 200-d avg
- 9.39
- 1y target
- 17.50
MAX chart
Events in this range
- Jan 5, 2022Dividend: 0.1
- Jan 5, 2022Split: 110 for 100
- Jul 26, 2024Rating: HC Wainwright & Co. · Buy → Buy
- Jul 26, 2024Rating: RBC Capital · Outperform → Outperform
- Sep 4, 2024Rating: HC Wainwright & Co. · Buy → Buy
- Oct 8, 2024Rating: RBC Capital · Outperform → Outperform
- Oct 25, 2024Rating: HC Wainwright & Co. · Buy → Buy
- Dec 6, 2024Rating: HC Wainwright & Co. · Buy → Buy
Signals (63)
| Name | Date | Ago |
|---|---|---|
| RSI: Oversold | Dec 16, 2025 | 10 months ago |
| RSI: Oversold | Oct 13, 2025 | 1 year ago |
| RSI: Oversold | Sep 8, 2025 | 1 year ago |
| SMA: Bearish | Aug 4, 2025 | 1 year ago |
| RSI: Oversold | Aug 4, 2025 | 1 year ago |
| SMA: Bearish | Jul 14, 2025 | 1 year ago |
| RSI: Oversold | Jul 14, 2025 | 1 year ago |
| SMA: Bullish | Jun 16, 2025 | 1 year ago |
| MACD: Buy Signal | Jun 16, 2025 | 1 year ago |
| SMA: Bearish | Jun 2, 2025 | 1 year ago |
| SMA: Bullish | May 16, 2025 | 1 year ago |
| RSI: Oversold | Mar 13, 2025 | 1 year ago |
| MACD: Sell Signal | Feb 20, 2025 | 1 year ago |
| SMA: Bearish | Jan 30, 2025 | 1 year ago |
| SMA: Bearish | Jan 30, 2025 | 1 year ago |
| SMA: Bullish | Jan 23, 2025 | 1 year ago |
| SMA: Bullish | Jan 23, 2025 | 1 year ago |
| SMA: Bearish | Dec 24, 2024 | 1 year ago |
| SMA: Bullish | Dec 10, 2024 | 1 year ago |
| SMA: Bearish | Dec 3, 2024 | 1 year ago |
| SMA: Bullish | Nov 26, 2024 | 1 year ago |
| SMA: Bearish | Nov 19, 2024 | 1 year ago |
| SMA: Bullish | Oct 14, 2024 | 2 years ago |
| MACD: Buy Signal | Oct 14, 2024 | 2 years ago |
| SMA: Bearish | Oct 7, 2024 | 2 years ago |
| SMA: Bullish | Sep 30, 2024 | 2 years ago |
| SMA: Bearish | Jul 29, 2024 | 2 years ago |
| SMA: Bullish | Jul 22, 2024 | 2 years ago |
| SMA: Bearish | May 10, 2024 | 2 years ago |
| MACD: Sell Signal | Apr 12, 2024 | 2 years ago |
| SMA: Bearish | Mar 28, 2024 | 2 years ago |
| RSI: Overbought | Feb 22, 2024 | 2 years ago |
| SMA: Bullish | Dec 14, 2023 | 2 years ago |
| SMA: Bearish | Dec 7, 2023 | 2 years ago |
| SMA: Bullish | Nov 22, 2023 | 2 years ago |
| SMA: Bearish | Nov 15, 2023 | 2 years ago |
| SMA: Bullish | Nov 8, 2023 | 2 years ago |
| SMA: Bullish | Oct 31, 2023 | 3 years ago |
| SMA: Bearish | Oct 24, 2023 | 3 years ago |
| MACD: Buy Signal | Sep 26, 2023 | 3 years ago |
| SMA: Bullish | Sep 19, 2023 | 3 years ago |
| SMA: Bearish | Aug 1, 2023 | 3 years ago |
| SMA: Bullish | Jul 18, 2023 | 3 years ago |
| SMA: Bearish | May 9, 2023 | 3 years ago |
| SMA: Bearish | May 9, 2023 | 3 years ago |
| SMA: Bullish | May 2, 2023 | 3 years ago |
| SMA: Bullish | May 2, 2023 | 3 years ago |
| SMA: Bearish | Apr 18, 2023 | 3 years ago |
| SMA: Bullish | Apr 11, 2023 | 3 years ago |
| SMA: Bearish | Mar 7, 2023 | 3 years ago |
| MACD: Sell Signal | Feb 7, 2023 | 3 years ago |
| SMA: Bearish | Jan 31, 2023 | 3 years ago |
| RSI: Overbought | Nov 8, 2022 | 3 years ago |
| SMA: Bullish | Oct 31, 2022 | 4 years ago |
| SMA: Bearish | Oct 10, 2022 | 4 years ago |
| SMA: Bullish | Oct 3, 2022 | 4 years ago |
| SMA: Bearish | Sep 26, 2022 | 4 years ago |
| SMA: Bullish | Jul 18, 2022 | 4 years ago |
| SMA: Bearish | Jul 11, 2022 | 4 years ago |
| SMA: Bullish | Jun 17, 2022 | 4 years ago |
| SMA: Bearish | May 2, 2022 | 4 years ago |
| RSI: Oversold | May 2, 2022 | 4 years ago |
| SMA: Bullish | Apr 11, 2022 | 4 years ago |
Key statistics
- Market cap
- 261.77M
- Enterprise value
- 299.78M
- Trailing P/E
- 58.71
- Forward P/E
- 17.13
- PEG ratio
- 0.00
- Price / sales
- 1.35
- Price / book
- 7.31
- EPS (TTM)
- 0.14
- Beta
- 0.54
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Profit margin
- 2.49%
- Revenue (TTM)
- 193.66M
- Revenue growth
- 0.10%
- Free cash flow
- 19.76M
- Total cash
- 37.63M
- Total debt
- 74.68M
- Return on equity
- 10.22%
- Shares outstanding
- 31.85M
- Short % of float
- 30.88%
- 50-day average
- 8.33
- 200-day average
- 9.39
Analyst view
Consensus: none
- Target (low)
- 11.00
- Target (mean)
- 17.50
- Target (high)
- 24.50
- Strong buy2
- Buy1
- Hold0
- Sell0
- Strong sell0
Next earnings
Nov 30, 2019
Expected Nov 30, 2019. Consensus EPS estimate 0.09.
Financials — quick view
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Nov 30, 2019 | Dec 1, 2010 | 0.00 | — | — | — |
| Nov 10, 2016 | Sep 1, 2016 | 0.00 | 0.02 | — | — |
| Aug 22, 2016 | Jun 1, 2016 | 0.00 | -0.01 | — | — |
| May 19, 2016 | Mar 1, 2016 | 0.00 | -0.01 | — | — |
| Mar 31, 2016 | Dec 1, 2015 | 0.00 | -0.04 | — | — |
| Nov 17, 2015 | Sep 1, 2015 | 0.00 | -0.01 | — | — |
Upgrades / downgrades
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Dec 6, 2024 | HC Wainwright & Co. | reit | Buy | Buy |
| Oct 25, 2024 | HC Wainwright & Co. | main | Buy | Buy |
| Oct 8, 2024 | RBC Capital | main | Outperform | Outperform |
| Sep 4, 2024 | HC Wainwright & Co. | reit | Buy | Buy |
| Jul 26, 2024 | RBC Capital | main | Outperform | Outperform |
| Jul 26, 2024 | HC Wainwright & Co. | main | Buy | Buy |
About Zynex, Inc.
Zynex, Inc., together with its subsidiaries, designs, manufactures, and markets medical devices to treat chronic and acute pain; and activate and exercise muscles for rehabilitative purposes with electrical stimulation. The company offers NexWave, a dual channel, multi-modality interferential current, transcutaneous electrical nerve stimulation, and neuromuscular electrical stimulation (NMES) device that is marketed to physicians and therapists by field sales representatives; NeuroMove, an electromyography and electric stimulation technology device; InWave, an electrical stimulation product for the treatment of female urinary incontinence; E-Wave, an NMES device; M-Wave, an NMES device. It also supplies private labeled products, including electrodes for the delivery of electrical current to the body, and batteries for use in electrotherapy products. In addition, the company distributes Comfortrac/Saunders for cervical traction, JetStream for hot/cold therapy, LSO Back Braces for lumbar support, and braces for rehabilitation support. Further, it offers Zynex Fluid Monitoring System (CM-1500); Zynex Wireless Fluid Monitoring System (CM-1600), a noninvasive monitoring device designed to measure relative changes in fluid volume in adult patients; NiCO CO-Oximeter, a laser-based noninvasive co-oximeter; and HemeOx tHb Oximeter, a laser-based total hemoglobin pulse oximeter. The company provides its products for use in pain management and control; stroke and spinal cord injury rehabilitation; hemodynamic monitoring and intravascular volume monitoring; and pulse oximetry monitoring. It sells its products through direct sales force primarily in the United States. Zynex, Inc. was founded in 1996 and is headquartered in Englewood, Colorado.
- Sector
- Healthcare
- Industry
- Medical Distribution
- Country
- United States
- Website
- zynex.com
News
- Critical Survey: Zynex (NASDAQ:ZYXI) versus Tactile Systems Technology (NASDAQ:TCMD)
- Head to Head Survey: Zynex (NASDAQ:ZYXI) & Cytosorbents (NASDAQ:CTSO)
- Kuehn Law Encourages Investors of Zynex, Inc. to Contact Law Firm
- Kuehn Law Encourages Investors of Zynex, Inc. to Contact Law Firm
- ZYXIQ CLASS ACTION DEADLINE TONIGHT: Faruqi & Faruqi, LLP Reminds Zynex (ZYXIQ) Investors of Securities Class Action Deadline on April 21, 2026
- Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of April 21, 2026 in Zynex, Inc. Lawsuit – ZYXIQ
- Bronstein, Gewirtz & Grossman LLC Urges Zynex, Inc. Investors to Act: Class Action Filed Alleging Investor Harm
- Bronstein, Gewirtz & Grossman LLC Urges Zynex, Inc. Investors to Act: Class Action Filed Alleging Investor Harm
- ZYXIQ SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Reminds Zynex (ZYXIQ) Investors of Securities Class Action Deadline on April 21, 2026
- Bronstein, Gewirtz & Grossman LLC Urges Zynex, Inc. Investors to Act: Class Action Filed Alleging Investor Harm
Your note
Sign in to keep a note on ZYXI — it syncs with the Stock Master app.
Insider holders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| CRESS MICHAEL D | Director | Stock Award(Grant) | May 15, 2024 | 22,587 |
| DISBROW JOSHUA R. | Director | Purchase | Jul 28, 2024 | 72,000 |
| LUCSOK ANNA | Chief Operating Officer | Stock Award(Grant) | Oct 28, 2024 | 96,137 |
| MICHAELS BARRY D | Director | Stock Award(Grant) | May 15, 2024 | 22,587 |
| MOORHEAD DANIEL J | Chief Financial Officer | Stock Award(Grant) | Dec 4, 2024 | 102,118 |
| SANDGAARD THOMAS | Chief Executive Officer | Sale | Nov 13, 2024 | 14,603,700 |
Institution ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Vanguard Group Inc | 3.65% | 1,178,106 | 9.68M | Sep 29, 2024 |
| Blackrock Inc. | 3.63% | 1,171,790 | 9.63M | Sep 29, 2024 |
| Hotchkis & Wiley Capital Management, LLC | 2.32% | 746,380 | 6.14M | Sep 29, 2024 |
| Nantahala Capital Management, LLC | 1.52% | 490,000 | 4.03M | Sep 29, 2024 |
| Geode Capital Management, LLC | 1.32% | 425,509 | 3.50M | Sep 29, 2024 |
| State Street Corporation | 1.17% | 378,030 | 3.11M | Sep 29, 2024 |
Fund ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Vanguard Total Stock Market Index Fund | 2.28% | 733,808 | 6.03M | Sep 29, 2024 |
| iShares Russell 2000 ETF | 1.16% | 372,520 | 3.06M | Oct 30, 2024 |
| Vanguard Extended Market Index Fund | 0.94% | 303,630 | 2.50M | Sep 29, 2024 |
| Hotchkis and Wiley Small Cap Diversified Value Fund | 0.63% | 202,200 | 1.66M | Sep 29, 2024 |
| Royce Micro-Cap Fund | 0.54% | 174,088 | 1.43M | Sep 29, 2024 |
| Fidelity Small Cap Index Fund | 0.48% | 155,062 | 1.27M | Aug 30, 2024 |